Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H15N5O2 |
Molar mass | 273.296 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.
Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action.[1] It was developed by a team at Roussel Uclaf in the 1990s[2]
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Hypnotics | |
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Antipsychotics | |
Sympatholytics (Antiadrenergics) |
|
Others | |
|